Monday, December 1, 2008 - 8:13PM EST

Clinical Trials

21. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.

Author
Crump M; Gluck S; Tu D; Stewart D; Levine M; Kirkbride P; Dancey J; O'Reilly S; Shore T; Couban S; Girouard C; Marlin S; Shepherd L; Pritchard KI;
Institution
National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada. michael.crump@uhn.on.ca
Journal
J Clin Oncol. 2008 Jan 1;26(1):37-43. Epub 2007 Nov 19.
Abstract URL
Click here to view abstract

22. Survival outcome and cost-effectiveness with docetaxel and paclitaxel in patients with metastatic breast cancer: a population-based evaluation.

Author
Vu T; Ellard S; Speers CH; Taylor SC; de Lemos ML; Hu F; Kuik K; Olivotto IA; Vu T; Ellard S; Speers CH; Taylor SC; de Lemos ML; Hu F; Kuik K; Olivotto IA;
Institution
Provincial Systemic Therapy Program, BC Cancer Agency, Vancouver, British Columbia, Canada.
Journal
Ann Oncol. 2008 Mar;19(3):461-4. Epub 2007 Nov 15.
Abstract URL
Click here to view abstract

23. Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208.

Author
Tokuda Y; Tajima T; Narabayashi M; Takeyama K; Watanabe T; Fukutomi T; Chou T; Sano M; Igarashi T; Sasaki Y; Ogura M; Miura S; Okamoto S; Ogita M; Kasai M; Kobayashi T; Fukuda H; Takashima S; Tobinai K;
Institution
Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. tokuda@is.icc.u-tokai.ac.jp
Journal
Cancer Sci. 2008 Jan;99(1):145-51. Epub 2007 Oct 25.
Abstract URL
Click here to view abstract

24. Adjuvant cyclic Tamoxifen and Megestrol acetate treatment in postmenopausal breast cancer patients--longterm follow-up.

Author
Fjosne HE; Jacobsen AB; Lundgren S;
Institution
Breast and Endocrine Unit, Department of Surgery, St. Olavs University Hospital, N-7006 Trondheim, Norway. hans.fjosne@stolav.no
Journal
Eur J Surg Oncol. 2008 Jan;34(1):6-12. Epub 2007 Sep 18.
Abstract URL
Click here to view abstract

25. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial.

Author
Pierce JP; Natarajan L; Caan BJ; Parker BA; Greenberg ER; Flatt SW; Rock CL; Kealey S; Al-Delaimy WK; Bardwell WA; Carlson RW; Emond JA; Faerber S; Gold EB; Hajek RA; Hollenbach K; Jones LA; Karanja N; Madlensky L; Marshall J; Newman VA; Ritenbaugh C; Thomson CA; Wasserman L; Stefanick ML;
Institution
Moores UCSD Cancer Center, University of California, San Diego, La Jolla , CA 92093-0901, USA. jppierce@ucsd.edu
Journal
JAMA. 2007 Jul 18;298(3):289-98.
Abstract URL
Click here to view abstract

26. Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF and weekly paclitaxel in patients with resected high-risk breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.

Author
Papadimitriou CA; Papakostas P; Timotheadou E; Aravantinos G; Bamias A; Fountzilas G;
Institution
Department of Clinical Therapeutics, Alexandra Hospital, University of Athens School of Medicine, Athens, Greece.chr_papadim@yahoo.gr
Journal
Cancer Invest. 2008 Jun;26(5):491-8.
Abstract URL
Click here to view abstract

27. Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99).

Author
Hess D; Koberle D; Thurlimann B; Pagani O; Schonenberger A; Mattmann S; Rochlitz C; Rauch D; Schuller JC; Ballabeni P; Ribi K;
Institution
Department of Internal Medicine, Division of Oncology-Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland. dagmar.hess@kssg.ch
Journal
Oncology. 2007;73(3-4):228-37. Epub 2008 Apr 17.
Abstract URL
Click here to view abstract

28. Phase II trial of pegylated liposomal doxorubicin-cyclophosphamide combination as first-line chemotherapy in older metastatic breast cancer patients.

Author
Kurtz JE; Rousseau F; Meyer N; Delozier T; Serin D; Nabet M; Djafari L; Dufour P;
Institution
Hopitaux Universitaires de Strasbourg, Strasbourg, France.
Journal
Oncology. 2007;73(3-4):210-4. Epub 2008 Apr 17.
Abstract URL
Click here to view abstract

29. Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.

Author
Lin NU; Carey LA; Liu MC; Younger J; Come SE; Ewend M; Harris GJ; Bullitt E; Van den Abbeele AD; Henson JW; Li X; Gelman R; Burstein HJ; Kasparian E; Kirsch DG; Crawford A; Hochberg F; Winer EP;
Institution
Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA.
Journal
J Clin Oncol. 2008 Apr 20;26(12):1993-9.
Abstract URL
Click here to view abstract

30. Weekly paclitaxel in the adjuvant treatment of breast cancer.

Author
Sparano JA; Wang M; Martino S; Jones V; Perez EA; Saphner T; Wolff AC; Sledge GW Jr; Wood WC; Davidson NE;
Institution
Eastern Cooperative Oncology Group, Philadelphia, USA. jsparano@montefiore.org
Journal
N Engl J Med. 2008 Apr 17;358(16):1663-71.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8